Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Wu Skincare CoROCO:6523 -0.45%83 EV-to-EBITDA is 7.98 as of Sep. 09, 2026, which is 21% below its 10-year median of 10.14. GuruFocus rates ROCO:6523 with a GF Score™ of 83/100 and a GF Value™ of NT$131.26 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,661 Consumer Packaged Goods companies, Dr Wu Skincare Co ranks better than 58.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dr Wu Skincare Co's enterprise value is NT$3,062 Mil.
Dr Wu Skincare Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$384 Mil. Therefore, Dr Wu Skincare Co's EV-to-EBITDA for today is 7.98.
The historical rank and industry rank for Dr Wu Skincare Co's EV-to-EBITDA or its related term are showing as below:
ROCO:6523'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.53 Med: 10.14 Max: 73.27
Current: 7.98
During the past 13 years, the highest EV-to-EBITDA of Dr Wu Skincare Co was 73.27. The lowest was 1.53. And the median was 10.14.
ROCO:6523's EV-to-EBITDA is ranked better than 58.52% of 1661
companies
in the Consumer Packaged Goods industry
Industry Median: 9.22
vs ROCO:6523: 7.98
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Dr Wu Skincare Co (ROCO:6523) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dr Wu Skincare Co's PE Ratio (TTM) for today is calculated as:
Dr Wu Skincare Co's share price for today is NT$89.40.
Dr Wu Skincare Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$6.604.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Dr Wu Skincare Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Dr Wu Skincare Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Wu Skincare Co EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Wu Skincare Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dr Wu Skincare Co's EV-to-EBITDA falls into.
Dr Wu Skincare Co's current Enterprise Value is NT$3,062 Mil.
Dr Wu Skincare Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$384 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Wu Skincare Co (ROCO:6523) has a EV-to-EBITDA of 7.98 as of Sep. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Wu Skincare Co. This is 21% below median its historical median of 10.14. Over the past decade, Dr Wu Skincare Co's EV-to-EBITDA has ranged from 1.53 to 73.27. According to the industry distribution chart, Dr Wu Skincare Co ranks #689 out of 1661 companies in the Consumer Packaged Goods industry, placing it in the top 41.5%.
Is Dr Wu Skincare Co's EV-to-EBITDA too high?
Dr Wu Skincare Co's current EV-to-EBITDA of 7.98 is 21% below median its 10-year median of 10.14. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 73.27. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.22. Dr Wu Skincare Co's value of 7.98 is 13.4% below this industry median. Based on the distribution chart, Dr Wu Skincare Co ranks #689 out of 1661 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Dr Wu Skincare Co has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Wu Skincare Co's EV-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Wu Skincare Co ranks #689 out of 1661 companies for EV-to-EBITDA. This puts Dr Wu Skincare Co in the upper half of its industry. The industry median EV-to-EBITDA is 9.22. Dr Wu Skincare Co's value of 7.98 is 13.4% below this benchmark. Historically, Dr Wu Skincare Co's own EV-to-EBITDA has ranged from 1.53 to 73.27 over the past decade. While the company's 10-year median is 10.14 vs. the industry median of 9.22, Dr Wu Skincare Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.22, based on 1,661 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Wu Skincare Co's current EV-to-EBITDA of 7.98 is 13.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dr Wu Skincare Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Wu Skincare Co's current EV-to-EBITDA is 7.98, which is 21% below median its own 10-year median of 10.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Wu Skincare Co stock overvalued right now?
Based on GuruFocus' analysis, Dr Wu Skincare Co (ROCO:6523) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$131.26, compared to a current price of NT$89.40 — trading 31.9% below its estimated fair value. The current EV-to-EBITDA is 7.98, which is 21% below median its 10-year median of 10.14 and 13.4% below the Consumer Packaged Goods industry median of 9.22. Dr Wu Skincare Co's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Dr Wu Skincare Co (ROCO:6523), the current EV-to-EBITDA is 7.98 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Wu Skincare Co (ROCO:6523) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Wu Skincare Co stock appears to be undervalued.
The current stock price of NT$89.40 is trading 31.9% below its estimated GF Value™ of NT$131.26.
GuruFocus considers Dr Wu Skincare Co to be Significantly Undervalued.
Key valuation signals for ROCO:6523:
EV-to-EBITDA: 7.98 (21% below median its 10-year median of 10.14)
GF Value™: NT$131.26 vs. price of NT$89.40 (31.9% below fair value)
Industry Position: 13.4% below the Consumer Packaged Goods median (#689 of 1661)
No single metric tells the full story. See the ROCO:6523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Wu Skincare Co Ltd is a Taiwan based company engaged in the research, development, production, wholesale and retail of cosmetics. It principally manufactures and sells cosmetics. The company offers products such as cosmetic masks, lotions, eye care products, moisturizers and others. The group derives its revenue from the sales of private label care products. It sells the products in Taiwan and internationally, of which majority of the revenue is derived from the sales made in Taiwan.
83GF Score
Get the complete analysis for ROCO:6523
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6523 has been successfully added to your 
